Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotin...
Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo
About this item
Full title
Publisher
Dove Medical Press
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press
Subjects
More information
Scope and Contents
Contents
Sheng Tan, Guoxiang Wang Department of Thoracic Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China Purpose: Erlotinib (ETB) is a well-established therapeutic for non-small-cell lung cancer (NSCLC). To overcome drug resistance and severe toxicities in the clinical application, redox-responsive...
Alternative Titles
Full title
Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2d9d0e0f63f049f594a69f6784d8af3e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d9d0e0f63f049f594a69f6784d8af3e
Other Identifiers
ISSN
1177-8881
E-ISSN
1177-8881
